Coagulation Factor XIII, A1 Polypeptide (F13A1) (N-Term) Peptide
Aperçu rapide pour Coagulation Factor XIII, A1 Polypeptide (F13A1) (N-Term) Peptide (ABIN8097582)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- F13A1 Peptide - N-terminal region
-
Séquence
- LPTVELQGVV PRGVNLQEFL NVTSVHLFKE RWDTNKVDHH TDKYENNKLI
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti- F13A1 Antibody (ARP81501_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
-
Sujet
-
Background Information: This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits, and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.
Alternative Symbols: F13A
-
Poids moléculaire
- 80 kDa
-
ID gène
- 2162
-
NCBI Accession
- NP_000120
-
UniProt
- P00488
Antigène
-
